XML 57 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Plan (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Feb. 10, 2021
Dec. 10, 2020
Feb. 10, 2020
Dec. 10, 2019
Dec. 10, 2018
Apr. 16, 2022
Dec. 22, 2021
Jun. 25, 2019
Jun. 30, 2022
Jan. 31, 2021
Jul. 15, 2020
Granted an option to purchase of common stock   325,000         325,000        
Weighted average excercise price   $ 2.00         $ 2.00        
Stock Options Granted To Employees [Member]                      
Granted an option to purchase of common stock   100,000                  
Weighted average excercise price   $ 2.00                  
Description of services agreement   On December 10, 2020, the Board granted five-year options to purchase 325,000 shares of common stock to each of its two officers. The options have an exercise price of $2.00 per share and are immediately exercisable   On December 10, 2019, the Board awarded an employee, the following three-year stock options under the Plan: (i) an option to purchase 33,334 shares of common stock, exercisable on December 10, 2019 at an exercise price of $2.00 per share (ii) an option to purchase 33,333 shares of common stock exercisable on December 10, 2020 at an exercise price of $2.00 per share, and (iii) an option to purchase 33,333 shares of common stock exercisable on December 10, 2021 at an exercise price of $2.00 per share, provided the employee is providing services to the Company at the time of exercise. On March 23, 2020, the Company accelerated the vesting provision to provide for the immediate vesting of such options. Such options expire on March 23, 2023. On December 10, 2018, the Board awarded an employee the following three-year stock options under the Plan: (i) an option to purchase 33,334 shares of common stock, exercisable on December 10, 2018 at an exercise price of $2.00 per share (ii) an option to purchase 33,333 shares of common stock exercisable on December 10, 2019 at an exercise price of $2.00 per share, and (iii) an option to purchase 33,333 shares of common stock exercisable on December 10, 2020 at an exercise price of $2.00 per share, provided the employee is providing services to the Company at the time of exercise. On March 23, 2020, the Company accelerated the vesting provision to provide for the immediate vesting of such options. 33,333 of such shares subject to the option were forfeited unexercised on December 10, 2021. The remaining option expires on March 23, 2023.   On December 22, 2021, the Board granted five-year options to purchase 325,000 shares of common stock to each of its two officers. The options have an exercise price of $2.00 per share and are immediately exercisable        
Unrecognized compensation                 $ 0    
Stock Options Granted To Officers [Member]                      
Granted an option to purchase of common stock   100,000       10,000 325,000        
Weighted average excercise price   $ 2.00         $ 2.00        
Description of services agreement   On June 25, 2019, the Company appointed John N. Bonfiglio, PhD as its chief operating officer, effective July 1, 2019. As compensation, Dr. Bonfiglio was granted a three-year stock option to purchase 100,000 shares of common stock at an exercise price of $2.00 per share, 50,000 of which shares vested upon grant and 25,000 shares vested on each of July 1, 2020 and July 1, 2021, provided Dr. Bonfiglio was in the employ of the Company on such dates. Mr. Bonfiglio was terminated as chief operating officer as of November 30, 2019. Accordingly, all unvested stock options terminated on such date. In January 2021, 50,000 vested options were forfeited         On December 22, 2021, under the Plan, the Board awarded an employee, an immediately exercisable three-year stock option to purchase 325,000 shares of the common stock of the Company at an exercise price of $2.00 per share On June 25, 2019, the Company appointed John N. Bonfiglio, PhD as its chief operating officer, effective July 1, 2019. As compensation, Dr. Bonfiglio was granted a three-year stock option to purchase 100,000 shares of common stock at an exercise price of $2.00 per share, 50,000 of which shares vested upon grant and 25,000 shares vested on each of July 1, 2020 and July 1, 2021, provided Dr. Bonfiglio was in the employ of the Company on such dates. Mr. Bonfiglio was terminated as chief operating officer as of November 30, 2019. Accordingly, all unvested stock options terminated on such date. In January 2021, 50,000 vested options were forfeited.      
Stock Options Granted To Science Advisor And Business Advisors [Member]                      
Granted an option to purchase of common stock     50,000                
Weighted average excercise price   $ 2.00 $ 2.00                
Expiry date February 10, 2024   February 10, 2023                
Unvested options 25,000                 25,000 25,000
Share exercisable     25,000